RT Journal Article
SR Electronic
T1 617 A Phase I study of a tumor-targeted, fibroblast activation protein (FAP)-CD40 agonist (RO7300490) in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A703
OP A703
DO 10.1136/jitc-2023-SITC2023.0617
VO 11
IS Suppl 1
A1 Melero, Ignacio
A1 Baradji, Maria Lostes
A1 Spanggaard, Iben
A1 Lee, Dae
A1 Spicer, James
A1 Thistlethwaite, Fiona C
A1 Symeonides, Stefan
A1 Oh, Do-Youn
A1 Hollebecque, Antoine
A1 Rusterholz, Corinne
A1 Cirovic, Olivera
A1 Zhao, Yvonne
A1 Kratochwil, Nicole
A1 Reis, Bernhard
A1 Epp, Alexandra
A1 Kazantzidis, Georgios
A1 Moreno, Victor
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A703.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.